Covid 19 in patients with systemic inflammatory diseases: impact on disease activity.

Current rheumatology reviews(2023)

引用 1|浏览0
暂无评分
摘要
Although our patients interrupted their DMARDs, our study demonstrates that disease activity as assessed by ASDAS and DAS28 in SpA and RA remained unchanged after COVID-19.
更多
查看译文
关键词
Ankylosing Spondylitis Disease,COVID-19,Disease activity,Methotrexate,Systemic inflammatory diseases,rheumatic diseases
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要